WaveMan · Form 4
Tang Kevin insider trades
> Search tickers & screens ⌘K
LIVE

Tang Kevin insider trades

Tang Kevin has filed 19 Form 4s with the SEC that we hold, for Boundless Bio, Inc. (BOLD) (10% owner), Aurinia Pharmaceuticals Inc. (AUPH) (Chief Executive Officer, Director, 10% owner), Fulcrum Therapeutics, Inc. (FULC) (10% owner) and LJPC (Director, 10% owner), among 7 companies in all. Across all of them we count 53 purchases worth $65.4M and 1 sale worth $54.4K reported on Form 4. In the last 12 months: 39 purchases ($28.1M) and 1 sale ($54.4K). The largest single trade was a purchase of 1,000,000 shares of Aurinia Pharmaceuticals Inc. worth $10.1M, dated 2025-08-01. Of 1 sale filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2022-01-14 and the latest 2026-08-28.

Boundless Bio, Inc. (BOLD)

10% owner · 7 filings · 23 purchases and sales
Trade dateCodeSharesValue as filedFiled
2026-06-25P, purchase reported on Form 4510$1.3K2026-06-29
2026-06-25P, purchase reported on Form 4145,880$361.8K2026-06-29
2026-06-26P, purchase reported on Form 475,047$191.4K2026-06-29
2026-06-26P, purchase reported on Form 4134$3402026-06-29
2026-06-29P, purchase reported on Form 4777$1.9K2026-06-29
2026-06-29P, purchase reported on Form 463,985$158.0K2026-06-29
2026-06-30P, purchase reported on Form 425,930$65.9K2026-07-02
2026-06-30P, purchase reported on Form 4100$2502026-07-02
2026-07-01P, purchase reported on Form 471,612$178.3K2026-07-02
2026-07-02P, purchase reported on Form 49,821$24.5K2026-07-02
2026-07-06P, purchase reported on Form 427,062$67.4K2026-07-08
2026-07-07P, purchase reported on Form 415,810$39.2K2026-07-08
2026-07-08P, purchase reported on Form 414,338$35.3K2026-07-08
2026-07-09P, purchase reported on Form 47$172026-07-13
2026-07-10P, purchase reported on Form 443,367$105.4K2026-07-13
2026-07-13P, purchase reported on Form 448,211$116.7K2026-07-13
2026-07-14P, purchase reported on Form 443,878$106.6K2026-07-16
2026-07-15P, purchase reported on Form 41,600$3.9K2026-07-16
2026-07-16P, purchase reported on Form 418,491$45.1K2026-07-16
2026-07-17P, purchase reported on Form 4265$6472026-07-21
2026-07-20P, purchase reported on Form 41,623$4.0K2026-07-21
2026-07-21P, purchase reported on Form 42,975$7.3K2026-07-21
2026-08-26S, sale reported on Form 418,300$54.4K2026-08-28

Aurinia Pharmaceuticals Inc. (AUPH)

Chief Executive Officer, Director, 10% owner · 5 filings · 23 purchases and sales
Trade dateCodeSharesValue as filedFiled
2024-12-05P, purchase reported on Form 4300,000$2.7M2024-12-09
2024-12-06P, purchase reported on Form 4400,000$3.6M2024-12-09
2024-12-09P, purchase reported on Form 4500,000$4.5M2024-12-09
2025-02-28P, purchase reported on Form 4399,280$3.1M2025-03-04
2025-03-03P, purchase reported on Form 4100,720$802.7K2025-03-04
2025-03-03P, purchase reported on Form 4351,962$2.8M2025-03-04
2025-03-04P, purchase reported on Form 4100,000$809.0K2025-03-04
2025-03-04P, purchase reported on Form 4500,000$4.0M2025-03-04
2025-03-04P, purchase reported on Form 4148,038$1.2M2025-03-04
2025-08-01P, purchase reported on Form 41,000,000$10.1M2025-08-05
2025-08-04P, purchase reported on Form 4100,000$1.1M2025-08-05
2025-08-05P, purchase reported on Form 4200,000$2.3M2025-08-05
2026-02-27P, purchase reported on Form 4214,839$3.0M2026-03-03
2026-02-27P, purchase reported on Form 41,600$23.0K2026-03-03
2026-02-27P, purchase reported on Form 4300,000$4.2M2026-03-03
2026-03-02P, purchase reported on Form 483,561$1.2M2026-03-03
2026-03-02P, purchase reported on Form 4115,792$1.6M2026-03-03
2026-03-03P, purchase reported on Form 4184,208$2.6M2026-03-03
2026-05-29P, purchase reported on Form 42,299$35.3K2026-06-02
2026-05-29P, purchase reported on Form 4262,682$4.0M2026-06-02
2026-06-01P, purchase reported on Form 4343,521$5.2M2026-06-02
2026-06-01P, purchase reported on Form 499$1.5K2026-06-02
2026-06-02P, purchase reported on Form 4206,005$3.1M2026-06-02

Fulcrum Therapeutics, Inc. (FULC)

10% owner · 2 filings · 6 purchases and sales
Trade dateCodeSharesValue as filedFiled
2026-07-13P, purchase reported on Form 412,966$45.9K2026-07-15
2026-07-14P, purchase reported on Form 453,651$191.0K2026-07-15
2026-07-14P, purchase reported on Form 475,952$271.9K2026-07-15
2026-07-15P, purchase reported on Form 4107,377$382.3K2026-07-15
2026-07-16P, purchase reported on Form 4116,671$415.3K2026-07-20
2026-07-17P, purchase reported on Form 450,945$179.3K2026-07-20

LJPC

Director, 10% owner · 2 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

JNCE

Director, 10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

OMIC

10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

TCRR

10% owner · 1 filing · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-05-11P, purchase reported on Form 438,765$75.6K2023-05-15
2023-05-12P, purchase reported on Form 46,183$12.1K2023-05-15
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1178579) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms